Chinese chipmaker Iluvatar CoreX to raise $850M in Hong Kong after stock surge

Shanghai Iluvatar CoreX Semiconductor Co. announced on July 8, 2026 its intention to raise approximately $850 million through a secondary stock offering on the Hong Kong Stock Exchange. The announcement came following a significant rally in the company's stock since its IPO in January 2026 — the shares have "skyrocketed," according to Bloomberg's description.

Why a secondary offering right now?

Iluvatar CoreX went public on the Hong Kong Stock Exchange in January 2026, and since then its shares have surged sharply in price. For a public company experiencing a rally, a secondary offering is a standard and logical move: a high stock price allows the company to raise more money by selling a smaller stake. This is not an urgent financing need, but rather the skillful use of a market window.

Bloomberg does not disclose the exact percentage increase in the stock price since the IPO, but the decision to raise $850 million speaks volumes about the level of investor demand. Stock buyers get the opportunity to enter a growing AI story through a liquid exchange-traded instrument — without the restrictions of closed venture rounds.

Against the backdrop of the AI industry's rise in China, supported by government programs and corporate demand, AI chip manufacturers have become one of the hottest sectors on the Hong Kong market. Large primary and secondary offerings of AI companies have followed one after another since 2025.

What is Iluvatar CoreX and what will the money be used for?

Shanghai Iluvatar CoreX Semiconductor Co. is one of China's leading AI accelerator developers. The company designs GPU-like processors for machine learning tasks: training and inference of large language models, computer vision, and scientific and engineering computing.

• Fundraising amount: approximately $850 million
• Format: secondary stock offering
• Venue: Hong Kong Stock Exchange
• Company IPO: January 2026
• Profile: developer of AI accelerators for ML and HPC

American export restrictions on advanced NVIDIA chips — the H100, H200, and B200 series — have created sustained demand in China for domestic alternatives. Iluvatar CoreX is among the main beneficiaries of this situation. The competitive landscape, meanwhile, is becoming increasingly complex: Huawei Ascend and other local players are also ramping up their AI chip manufacturing capabilities. The funds raised will help the company maintain its technological leadership. Bloomberg does not disclose specific spending targets.

Why Hong Kong and not mainland exchanges?

The Hong Kong Stock Exchange remains the primary gateway for Chinese technology companies targeting international capital. Listing here provides access to global institutional investors operating within common law frameworks, whereas direct foreign capital access to Shanghai and Shenzhen exchanges is significantly restricted.

In 2025–2026, Hong Kong has deliberately positioned itself as a regional AI financial hub: the SFC regulator has simplified certain requirements for technology issuers, and several major AI companies have already conducted primary and secondary offerings here. For Iluvatar CoreX, which already completed its IPO on the Hong Kong exchange in January 2026, this is a logical venue for its first major secondary offering — the investor base is already established and listing conditions are familiar.

What this means

Raising $850 million confirms that global investors view the Chinese AI chip market as long-term structural growth rather than short-term hype. Iluvatar CoreX skillfully leverages two tailwinds — elevated valuations and the scarcity of Western accelerators — to build a capital base for the next round of competitive competition. How effectively the company converts the raised funds into technological leadership will be evident in the coming operational year.